Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair

Nucleic Acids Research

Volumn 34, Issue 6, 2006, Pages 1685-1691

  Bryant, Helen E ^a   Helleday, Thomas ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 1,8 NAPHTHALAMIDE; ATM PROTEIN; DNA DEPENDENT PROTEIN KINASE; KU 55933; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NU 7026; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; 1 NAPHTHYLAMINE; 4 AMINO 1,8 NAPHTHALIMIDE; 4-AMINO-1,8-NAPHTHALIMIDE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DRUG DERIVATIVE; ENZYME INHIBITOR; NAPHTHALIMIDE DERIVATIVE; POLY(ADP RIBOSE)POLYMERASE 1, MOUSE; POLY(ADP-RIBOSE)POLYMERASE-1, MOUSE; PROTEIN SERINE THREONINE KINASE; QUINOLONE DERIVATIVE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; HOMOLOGOUS RECOMBINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG ANTAGONISM; GENE DELETION; GENETIC RECOMBINATION; GENETICS; HAMSTER; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALIA;

1-NAPHTHYLAMINE; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CELL SURVIVAL; CRICETINAE; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE DELETION; MICE; MUTATION; NAPHTHALIMIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN-SERINE-THREONINE KINASES; QUINOLONES; RECOMBINATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 33645532464     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl108     Document Type: Article

References (55)

1. Lindahl,T,, Satoh,M.S., Poirier,G.G. and Klungland,A. (1995) Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci., 20, 405-411.
2. D'Amours,D., Desnoyers,S., D'Silva,I. and Poirier,G.G. (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J., 342, 249-268.
3. de Murcia,J.M., Niedergang,C., Trucco,C., Ricoul,M., Dutrillaux,B., Mark,M., Oliver,F.J., Masson,M., Dierich,A., LeMeur,M., Walztinger,C., Chambon,P. and de Murcia,G. (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl Acad. Sci. USA, 94, 7303-7307.
4. Caldecott,K., Aoufouchi,S., Johnson,P. and Shall,S. (1996) XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick- sensor' in vitro. Nucleic Acids Res., 24, 4387-4394.
5. Masson,M., Niedergang,C., Schreiber,V., Muller,S., Menissier-de Murcia,J. and de Murcia,G. (1998) XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell Biol., 18, 3563-3571.
6. Wang,Z.Q., Stingl,L., Morrison,C., Jantsch,M., Los,M., Schulze-Osthoff,K. and Wagner,E.F. (1997) PARP is important for genomic stability but dispensable in apoptosis. Genes Dev., 11, 2347-2358.
7. Schultz,N., Lopez,E., Saleh-Gohari,N. and Helleday,T. (2003) Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. Nucleic Acids. Res., 31, 4959-4964.
8. Audebert,M., Salles,B. and Calsou,P. (2004) Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem., 279, 55117-55126.
9. Conde,C., Mark,M., Oliver,F.J., Huber,A., de Murcia,G. and Menissier-de Murcia,J. (2001) Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice. EMBO J., 20, 3535-3543.
10. Arundel-Suto,C.M., Scavone,S.V., Turner,W.R., Suto,M.J. and Sebolt-Leopold,J.S. (1991) Effects of PD 128763, a new potent inhibitor of poly(ADP-ribose) polymerase, on X-ray-induced cellular recovery processes in chinese hamster V79 Cells. Radiation Res., 126, 367-371.
11. Bowman,K.J., White,A., Golding,B.T., Griffin,R.J. and Curtin,N.J. (1998) Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br. J. Cancer, 78, 1269-1277.
12. Weltin,D., Holl,V., Hyun,J.W., Dufour,P., Marchal,J. and Bischoff,P. (1997) Effect of 6(5H)-phenanthridinone, a poly (ADP-ribose) polymerase inhibitor, and ionizing radiation on the growth of cultured lymphoma cells. Int. J. Radiat. Biol., 72, 685-692.
13. Bowman,K.J., Newell,D.R., Calvert,A.H. and Curtin,N.J. (2001) Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. Br. J. Cancer, 84, 106-112.
14. Delaney,C.A., Wang,L.Z., Kyle,S., White,A.W., Calvert,A.H., Curtin,N.J., Durkacz,B.W., Hostomsky,Z. and Newell,D.R. (2000) Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clin. Cancer Res., 6, 2860-2867.
15. Tentori,L., Portarena,I. and Graziani,G. (2002) Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol. Res., 45, 73-85.
16. Boulton,S., Pemberton,L.C., Porteous,J.K., Curtin,N.J., Griffin,R.J., Golding,B.T. and Durkacz,B.W. (1995) Potentiation of temozolomide-induced cytotoxicity: A comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors. Br. J. Cancer, 72, 849-856.
17. Curtin,N.J. (2005) PARP inhibitors for cancer therapy. Expert Rev. Mol. Med., 7, 1-20.
18. Curtin,N.J., Wang,L.Z., Yiakouvaki,A., Kyle,S., Arris,C.A., Canan-Koch,S., Webber,S.E., Durkacz,B.W., Calvert,H.A., Hostomsky,Z. et al. (2004) Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. Clin. Cancer Res., 10, 881-889.
19. Cheng,C.L., Johnson,S.P., Keir,S.T., Quinn,J.A., Ali-Osman,F., Szabo,C., Li,H., Salzman,A.L., Dolan,M.E., Modrich,P., Bigner,D.D. and Friedman,H.S. (2005) Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol. Cancer Ther., 4, 1364-1368.
20. Bryant,H.E., Schultz,N., Thomas,H.D., Parker,K.M., Flower,D., Lopez,E., Kyle,S.,Meuth,M., Curtin,N.J. and Helleday,T. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature, 434, 913-917.
21. Farmer,H., McCabe,N., Lord,C.J., Tutt,A.N., Johnson,D.A., Richardson,T.B., Santarosa,M., Dillon,K.J., Hickson,I., Knights,C., Martin,N.M., Jackson,S.P., Smith,G.C. and Ashworth,A. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 434, 917-921.
22. Schlicker,A., Peschke,P., Burkle,A., Hahn,E.W. and Kim,J.H. (1999) 4-Amino-1,8-naphthalimide: A novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer. Int. J. Radiat. Biol., 75, 91-100.
23. Hickson,I., Zhao,Y., Richardson,C.J., Green,S.J., Martin,N.M., Orr,A.I., Reaper,P.M., Jackson,S.P., Curtin,N.J. and Smith,G.C. (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res., 64, 9152-9159.
24. Veuger,S.J., Curtin,N.J., Smith,G.C. and Durkacz,B.W. (2004) Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair. Oncogene, 23, 7322-7329.
25. Wang,Z.-Q., Auer,B., Stingl,L., Berghammer,H., Haidacher,D., Schweiger,M. and Wagner,E.F. (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev., 9, 509-520.
26. Masutani,M., Nozaki,T., Nishiyama,E., Shimokawa,T., Tachi,Y., Suzuki,H., Nakagama,H., Wakabayashi,K. and Sugimura,T. (1999) Function of poly(ADP-ribose) polymerase in response to DNA damage: Gene-disruption study in mice. Mol. Cell Biochem., 193, 149-152.
27. Menisser-de Murcia,J., Mark,M., Wendling,O., Wynshaw-Boris,A. and de Murcia,G. (2001) Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Mol. Cell Biol., 21, 1828-1832.
28. Henrie,M.S., Kurimasa,A., Burma,S., Menissier-de Murcia,J., de Murcia,G., Li,G.C. and Chen,D.J. (2003) Lethality in PARP-1/Ku80 double mutant mice reveals physiological synergy during early embryogenesis. DNA Repair (Amst), 2, 151-158.
29. Morrison,C., Smith,G.C., Stingl,L., Jackson,S.P., Wagner,E.F. and Wang,Z.Q. (1997) Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nature Genet., 17, 479-482.
30. Sancar,A., Lindsey-Boltz,L.A., Unsal-Kacmaz,K. and Linn,S. (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem., 73, 39-85.
31. Schultz,N., Lopez,E., Saleh-Gohari,N. and Helleday,T. (2003) Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. Nucleic Acids Res., 31, 4959-4964.
32. Saleh-Gohari,N., Bryant,H.E., Schultz,N., Parker,K.M., Cassel,T.N. and Helleday,T. (2005) Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks. Mol. Cell Biol., 25, 7158-7169.
33. Arnaudeau,C., Lundin,C. and Helleday,T. (2001) DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J. Mol. Biol., 307, 1235-1245.
34. Helleday,T., Arnaudeau,C. and Jenssen,D. (1998) A partial hprt gene duplication generated by non-homologous recombination in V79 Chinese hamster cells is eliminated by homologous recombination. J. Mol. Biol., 279, 687-694.
35. Bartek,J., Lukas,C. and Lukas,J. (2004) Checking on DNA damage in S phase. Nature Rev. Mol. Cell Biol., 5, 792-804.
36. Abraham,R.T. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15, 2177-2196.
37. Bolderson,E., Scorah,J., Helleday,T., Smythe,C. and Meuth,M. (2004) ATM is required for the cellular response to thymidine induced replication fork stress. Hum. Mol. Genet., 31, 2937-2945.
38. Khanna,K.K. and Jackson,S.P. (2001) DNA double-strand breaks: Signaling, repair and the cancer connection. Nature Genet., 27, 247-254.
39. Kurose,A., Tanaka,T., Huang,X., Halicka,H.D., Traganos,F., Dai,W. and Darzynkiewicz,Z. (2005) Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis. Cytometry A, 68, 1-9.
40. Strumberg,D., Pilon,A.A., Smith,M., Hickey,R., Malkas,L. and Pommier,Y. (2000) Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell Biol., 20, 3977-3987.
41. Morrison,C., Sonoda,E., Takao,N., Shinohara,A., Yamamoto,K. and Takeda,S. (2000) The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J., 19, 463-471.
42. Veuger,S.J., Curtin,N.J., Smith,G.C. and Durkacz,B.W. (2004) Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair. Oncogene, 23, 7322-7329.
43. Riballo,E., Kuhne,M., Rief,N., Doherty,A., Smith,G.C., Recio,M.J., Reis,C., Dahm,K., Fricke,A., Krempler,A., Parker,A.R., Jackson,S.P., Gennery,A., Jeggo,P.A. and Lobrich,M. (2004) A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell, 16, 715-724.
44. Ma,Y., Schwarz,K. and Lieber,M.R. (2005) The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. DNA Repair (Amst), 4, 845-851.
45. Zou,L. and Elledge,S.J. (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science, 300, 1542-1548.
46. Siu,W.Y., Lau,A., Arooz,T., Chow,J.P., Ho,H.T. and Poon,R.Y. (2004) Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. Mol. Cancer Ther., 3, 621-632.
47. Cliby,W.A., Lewis,K.A., Lilly,K.K. and Kaufmann,S.H. (2002) S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J. Biol. Chem., 277, 1599-1606.
48. Rosenwald,A., Chuang,E.Y., Davis,R.E., Wiestner,A., Alizadeh,A.A., Arthur,D.C., Mitchell,J.B., Marti,G.E., Fowler,D.H., Wilson,W.H. and Staudt,L.M. (2004) Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood, 104, 1428-1434.
49. Stilgenbauer,S., Schaffner,C., Litterst,A., Liebisch,P., Gilad,S., Bar-Shira,A., James,M.R., Lichter,P. and Dohner,H. (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature Med., 3, 1155-1159.
50. Stankovic,T., Hubank,M., Cronin,D., Stewart,G.S., Fletcher,D., Bignell,C.R., Alvi,A.J., Austen,B., Weston,V.J., Fegan,C., Byrd,P.J., Moss,P.A.H. and Taylor,A.M.R. (2004) Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses. Blood, 103, 291-300.
51. Stankovic,T., Weber,P., Stewart,G., Bedenham,T., Murray,J., Byrd,P.J., Moss,P.A. and Taylor,A.M.R. (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet, 353, 26-29.
52. Bullrich,F., Rasio,D., Kitada,S., Starostik,P., Kipps,T., Keating,M., Albitar,M., Reed,J.C. and Croce,C.M. (1999) ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res., 59, 24-27.
53. Austen,B., Powell,J.E., Alvi,A., Edwards,I., Hooper,L., Starczynski,J., Taylor,A.M.R., Fegan,C., Moss,P. and Stankovic,T. (2005) Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. Blood, 106, 3175-3182.
54. Stankovic,T., Stewart,G.S., Fegan,C., Biggs,P., Last,J., Byrd,P.J., Keenan,R.D., Moss,P.A.H. and Taylor,A.M.R. (2002) Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood, 99, 300-309.
55. Schaffner,C., Stilgenbauer,S., Rappold,G.A., Dohner,H. and Lichter,P. (1999) Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood, 94, 748-753.